The global fill-finish manufacturing market is expected to reach USD 4.47 Billion by 2022 from USD 2.96 Billion in 2017, at a CAGR of 8.6% during the forecast period (2017–2022).
Browse 81 market data Tables and 23 Figures spread through 123 Pages and in-depth TOC on "Fill Finish Manufacturing Market"
The consumables segment is expected to hold the largest market share during the forecast period
On the basis of product, the fill-finish manufacturing market is segmented into consumables and instruments. In 2017, the consumables segment is expected to account for the largest share of the market.
The dominant share of this segment can be attributed to the wide applications of vials in lyophilization, increasing demand for prefilled syringes, and the growth of the plastic prefilled syringes market.
On the basis of end user, the market is classified into contract manufacturing organizations, biopharmaceutical companies, and other end users.
Download the PDF Brochure@ www.marketsandmarkets.com/pdfdownload.asp?id=6249609
The contract manufacturing organizations segment is the fastest-growing segment in the fill-finish manufacturing market. This can primarily be attributed to the rising demand for outsourcing the fill-finish manufacturing process and growing number of new entrants in the biologics manufacturing market.
Europe is expected to dominate the fill-finish manufacturing market in 2017
In 2017, Europe is expected to account for the largest share of the global fill-finish manufacturing market. The large share of the European region is mainly attributed to factors such as the emergence of biosimilar market due to patent expiry of key biologic products, rising incidence of chronic disorders, and increasing focus of major players on enhancing their presence in Europe.
The APAC region is expected to grow at the highest CAGR over the next five years. The growth of the fill-finish manufacturing market in this region is fueled by the overall growth in the biopharmaceutical industry.
The key players operating in this market include Becton, Dickinson and Company (US), West Pharmaceutical Services, Inc. (West Pharmaceutical Services) (US), Gerresheimer AG (Gerresheimer) (Germany), Robert Bosch GmbH (Robert Bosch) (Germany), IMA (Italy), OPTIMA (Germany), and Nipro Medical Corporation (US).
Get the Sample Pages@ www.marketsandmarkets.com/requestsample.asp?id=6249609
Category: Market Research Publishers and RetailersCompany about: MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth ...